Related Experiment Video

Updated: May 25, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras

Yael Gus-Brautbar1, Derek Johnson, Li Zhang

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Molecular Cell
|February 14, 2012
PubMed

Insights

Tumorigenesis and Inflammation Inhibitor 2 (TIPE2) acts as a bridge between inflammation and cancer by inhibiting the Ras signaling pathway. Loss of TIPE2 is linked to human liver cancer, suggesting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • The link between chronic inflammation and cancer development is well-established.
  • However, the precise molecular pathways connecting inflammation to cancer remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of TIPE2 (Tumorigenesis and Inflammation Inhibitor 2) in bridging inflammation and cancer.
  • To investigate TIPE2's mechanism of action via the Ras signaling pathway.

Main Methods:

  • Investigated TIPE2's interaction with RalGDS proteins, key effectors of Ras.
  • Assessed the impact of TIPE2 deficiency and overexpression on Ras-Ral-AKT signaling.
  • Analyzed TIPE2 expression levels in human hepatocellular carcinoma (HCC) samples.

Main Results:

  • TIPE2 directly binds to RalGDS, inhibiting Ras-mediated activation of Ral and AKT signaling.
  • TIPE2 deficiency results in elevated Ral and AKT activity, promoting cell survival, migration, and exocyst complex dysregulation.
  • TIPE2 overexpression induces apoptosis and suppresses Ras-driven tumorigenesis in vivo.
  • Significantly reduced or absent TIPE2 expression was observed in human liver cancer tissues.

Conclusions:

  • TIPE2 functions as a critical negative regulator of both inflammatory responses and cancer progression.
  • TIPE2's tumor-suppressive role and its downregulation in hepatic cancer highlight its potential as a therapeutic target for inflammatory and neoplastic diseases.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...